National Planning Corporation’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,073
Closed -$220K 682
2017
Q3
$220K Sell
1,073
-101
-9% -$23.5K 0.02% 608
2017
Q2
$286K Buy
1,174
+291
+33% +$68.4K 0.02% 570
2017
Q1
$211K Sell
883
-374
-30% -$87.1K 0.02% 626
2016
Q4
$289K Sell
1,257
-133
-10% -$27.6K 0.02% 511
2016
Q3
$277K Buy
1,390
+161
+13% +$39.3K 0.02% 502
2016
Q2
$308K Sell
1,229
-132
-10% -$30.4K 0.02% 494
2016
Q1
$274K Sell
1,361
-438
-24% -$125K 0.02% 485
2015
Q4
$493K Buy
1,799
+536
+42% +$160K 0.04% 404
2015
Q3
$389K Buy
1,263
+38
+3% +$11.7K 0.04% 398
2015
Q2
$389K Buy
1,225
+169
+16% +$50.4K 0.04% 414
2015
Q1
$302K Buy
1,056
+402
+61% +$115K 0.03% 488
2014
Q4
$173K Buy
+654
New +$163K 0.01% 717

Other funds holding AGN

National Planning Corporation's AGN Position: Q4 2017 in Review

National Planning Corporation sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,073 shares — an estimated $220K sold.

National Planning Corporation first reported a position in AGN in Q4 2014 and held it in 12 quarters. The position peaked at $493K in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • National Planning Corporation reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 1,073 Allergan plc shares in Q4 2017, an estimated $220K.
  • National Planning Corporation first reported a position in Allergan plc in Q4 2014 and held it in 12 quarters.
  • National Planning Corporation's Allergan plc position peaked at $493K in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.